Publication | Closed Access

Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study

Hematological MalignancyBone Marrow FailureLaboratory HematologyHematologySingle-centre StudyLow-risk Myelodysplastic SyndromesMyelopoiesisGranulocyte Colony-stimulating FactorMedicineAplastic Anemia